Bristol Myers Squibb, colosso farmaceutico con sede principale negli Stati Uniti, ha annunciato un secondo NVIDIA DGX SuperPOD basato su otto sistemi DGX Vera Rubin NVL72 che sar� accessibile da tutte le sedi distribuite a livello mondiale

NEW YORK, July 20 : Bristol Myers Squibb said on Monday it is buying the latest-generation computing system from chip company Nvidia to support its use of artificial intelligence…

Bristol-Myers Squibb and Nvidia built an AI supercomputer for drug discovery that cut computing costs 55%, joining a pharma industry AI infrastructure race.

Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA

Bristol Myers Squibb adopts NVIDIA DGX SuperPOD to train next-gen AI models and accelerate drug discovery.

Bristol Myers Squibb acquires Nvidia's Vera Rubin DGX SuperPOD for drug discovery, becoming the first pharma company to deploy the latest AI computing

El nuevo clúster de cómputo de Nvidia y BMS se ubicará en los centros de datos de Equinix bajo un acuerdo de co-ubicación

Bristol Myers Squibb, colosso farmaceutico con sede principale negli Stati Uniti, ha annunciato un secondo NVIDIA DGX SuperPOD basato su otto sistemi DGX Vera Rubin NVL72 che sar�…